196 related articles for article (PubMed ID: 33242831)
21. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
Weisz A; Basile W; Scafoglio C; Altucci L; Bresciani F; Facchiano A; Sismondi P; Cicatiello L; De Bortoli M
J Cell Physiol; 2004 Sep; 200(3):440-50. PubMed ID: 15254972
[TBL] [Abstract][Full Text] [Related]
22. Different epigenetic mechanisms of ERα implicated in the fate of fulvestrant-resistant breast cancer.
Tsuboi K; Kaneko Y; Nagatomo T; Fujii R; Hanamura T; Gohno T; Yamaguchi Y; Niwa T; Hayashi SI
J Steroid Biochem Mol Biol; 2017 Mar; 167():115-125. PubMed ID: 27888136
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptor α regulates the expression of syndecan-1 in human breast carcinoma cells.
Fleurot E; Goudin C; Hanoux V; Bonnamy PJ; Levallet J
Endocr Relat Cancer; 2019 Jun; 26(6):615-628. PubMed ID: 30978702
[TBL] [Abstract][Full Text] [Related]
24. BCAR4 facilitates trastuzumab resistance and EMT in breast cancer via sponging miR-665 and interacting with YAP1.
Ye X; Liu Q; Qin X; Ma Y; Sheng Q; Wu X; Chen S; Huang L; Sun Y
FASEB J; 2024 Apr; 38(7):e23589. PubMed ID: 38572594
[TBL] [Abstract][Full Text] [Related]
25. Estrogen-induced epigenetic silencing of
Muhammad JS; Bajbouj K; Shafarin J; Hamad M
Epigenetics; 2020 Dec; 15(12):1302-1318. PubMed ID: 32476555
[TBL] [Abstract][Full Text] [Related]
26. SHISA3, an antagonist of the Wnt/β-catenin signaling, is epigenetically silenced and its ectopic expression suppresses growth in breast cancer.
Shahzad N; Munir T; Javed M; Tasneem F; Aslam B; Ali M; Mutahir Z; Akhtar Ali M; Umer M; Ahmad M; Farooq K; Hassan U; Mustafa T; Anjum RS; Shakoori AR
PLoS One; 2020; 15(7):e0236192. PubMed ID: 32692756
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor alpha/beta isoforms, but not betacx, modulate unique patterns of gene expression and cell proliferation in Hs578T cells.
Secreto FJ; Monroe DG; Dutta S; Ingle JN; Spelsberg TC
J Cell Biochem; 2007 Aug; 101(5):1125-47. PubMed ID: 17520659
[TBL] [Abstract][Full Text] [Related]
28. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
[TBL] [Abstract][Full Text] [Related]
29. Interplay of ERα binding and DNA methylation in the intron-2 determines the expression and estrogen regulation of cystatin A in breast cancer cells.
John Mary DJS; Sikarwar G; Kumar A; Limaye AM
Mol Cell Endocrinol; 2020 Mar; 504():110701. PubMed ID: 31926189
[TBL] [Abstract][Full Text] [Related]
30. [Study of the CpG methylation status of ER alpha gene in estrogen receptor alpha-negative breast cancer cell lines and the role of hydralazine demethylation].
Tang B; Jiang J
Zhonghua Bing Li Xue Za Zhi; 2005 May; 34(5):283-7. PubMed ID: 16181550
[TBL] [Abstract][Full Text] [Related]
31. Methylome and transcriptome analyses reveal insights into the epigenetic basis for the good survival of hypomethylated ER-positive breast cancer subtype.
Chen XQ; Zhang F; Su QC; Zeng C; Xiao FH; Peng Y
Clin Epigenetics; 2020 Jan; 12(1):16. PubMed ID: 31959227
[TBL] [Abstract][Full Text] [Related]
32. Estrogen regulates miRNA expression: implication of estrogen receptor and miR-124/AKT2 in tumor growth and angiogenesis.
Jiang CF; Li DM; Shi ZM; Wang L; Liu MM; Ge X; Liu X; Qian YC; Wen YY; Zhen LL; Lin J; Liu LZ; Jiang BH
Oncotarget; 2016 Jun; 7(24):36940-36955. PubMed ID: 27175587
[TBL] [Abstract][Full Text] [Related]
33. CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer.
Shehwana H; Keskus AG; Ozdemir SE; Acikgöz AA; Biyik-Sit R; Cagnan I; Gunes D; Jahja E; Cingir-Koker S; Olmezer G; Sucularli C; Konu O
Cell Oncol (Dordr); 2021 Apr; 44(2):453-472. PubMed ID: 33469842
[TBL] [Abstract][Full Text] [Related]
34. Regulation of IL-20 Expression by Estradiol through KMT2B-Mediated Epigenetic Modification.
Su CH; Lin IH; Tzeng TY; Hsieh WT; Hsu MT
PLoS One; 2016; 11(11):e0166090. PubMed ID: 27806114
[TBL] [Abstract][Full Text] [Related]
35. Stilbenoid-Mediated Epigenetic Activation of Semaphorin 3A in Breast Cancer Cells Involves Changes in Dynamic Interactions of DNA with DNMT3A and NF1C Transcription Factor.
Beetch M; Lubecka K; Shen K; Flower K; Harandi-Zadeh S; Suderman M; Flanagan JM; Stefanska B
Mol Nutr Food Res; 2019 Oct; 63(19):e1801386. PubMed ID: 31327173
[TBL] [Abstract][Full Text] [Related]
36. Unexpected Impact of a Hepatitis C Virus Inhibitor on 17β-Estradiol Signaling in Breast Cancer.
Bartoloni S; Leone S; Acconcia F
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408555
[TBL] [Abstract][Full Text] [Related]
37. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells.
Wang B; Li D; Rodriguez-Juarez R; Farfus A; Storozynsky Q; Malach M; Carpenter E; Filkowski J; Lykkesfeldt AE; Kovalchuk O
BMC Cancer; 2018 Aug; 18(1):817. PubMed ID: 30103729
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic regulation of ID4 in breast cancer: tumor suppressor or oncogene?
Nasif D; Campoy E; Laurito S; Branham R; Urrutia G; Roqué M; Branham MT
Clin Epigenetics; 2018 Aug; 10(1):111. PubMed ID: 30139383
[TBL] [Abstract][Full Text] [Related]
39. The knockdown of SNHG3 inhibits the progression of laryngeal squamous cell carcinoma by miR-340-5p/YAP1 axis and Wnt/β-catenin pathway.
Kang R; Yao DF; Xu GZ; Zhou YH
Neoplasma; 2020 Sep; 67(5):1094-1105. PubMed ID: 32538668
[TBL] [Abstract][Full Text] [Related]
40. Estrogen-ERα signaling and DNA hypomethylation co-regulate expression of stem cell protein PIWIL1 in ERα-positive endometrial cancer cells.
Chen Z; Yang HJ; Lin Q; Zhu MJ; Yu YY; He XY; Wan XP
Cell Commun Signal; 2020 Jun; 18(1):84. PubMed ID: 32503542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]